Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early phase II study of AT-877ER in pulmonary arterial hypertension
jRCT2080220801Phase 2
- Sponsor
- Asahi Kasei Corporation
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing AT-877ER arm with Placebo arm (2 arms).
02
Drugs
AT-877ER
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on jRCT2080220801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220801.